The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...
Incyte and Genesis have entered a strategic partnership for the research, discovery and development of new small-molecule ...
CSL Behring KK has gained approval from Japan's MHLW to manufacture and market subcutaneous injection 200mg Andembry pens.
BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
How can pharmaceutical firms shore up their sustainability credentials at a time when the entire research landscape is turning on its head? A recent webinar from supply chain leaders World Courier and ...
X4 has entered an exclusive agreement with taiba rare for distributing and commercialising Xolremdi in select Middle Eastern ...
While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...
ImmunityBio has gained the FDA authorisation for an EAP to supply an alternative source of BCG for treating bladder cancer.
FDA has granted priority review for Boehringer Ingelheim’s zongertinib NDA for treating unresectable or metastatic NSCLC.
The World Health Organization (WHO) said it will conduct another mass vaccination round in the Gaza Strip to protect children ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results